Preparing for China · patient guide

Lymphoma Treatment Review in China: Preparing the Exact Pathology Diagnosis

A lymphoma treatment review in China begins with the exact pathology diagnosis, not with a treatment list. Lymphoma includes Hodgkin and non-Hodgkin types, and the subtype changes the discussion. Before a specialist can advise, they need your original pathology report, the biopsy material or slides, and the imaging that staged the disease. This guide explains what those records clarify, what stays uncertain remotely, and how to organise the gaps without ordering tests yourself.

Go to the practical guidance ↓
AI illustration: A doctor discusses medical information with a couple in a consultation room.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

Why the exact pathology diagnosis decides the review

Lymphoma is not one disease. The National Cancer Institute describes lymphoma as a group that includes Hodgkin lymphoma and non-Hodgkin lymphoma, and the exact diagnosis matters when treatment is discussed. A review that starts from 'lymphoma' as a single label cannot answer the practical question an overseas patient usually has: does the diagnosis on file match the disease being treated, and is anything missing before a treatment plan is confirmed?

The pathology report is the document that names the subtype. It typically records the tissue sampled, the appearance of the cells, and the markers used to classify them. A treatment review in China is therefore a records-based exercise first. The specialist reads what your own pathologist concluded, compares it with the clinical history and imaging, and decides whether the diagnosis is complete enough to plan from. That is different from a general second opinion about whether you should travel.

What the original pathology report and slides can clarify

The original report is more useful than a summary. Ask your treating hospital for the full pathology report, including any addendum or molecular section, rather than a one-line diagnosis. If a review is being considered, the receiving pathologist may want the stained slides or the tissue block itself, because re-reading the material is how a diagnosis is checked. A photocopy of the report alone cannot always confirm the subtype.

The report also shows what was not done. If a marker or a molecular test was not performed, that is a gap the specialist can identify. It does not mean the original diagnosis is wrong, and it does not mean you should arrange that test yourself. It means the question 'is this diagnosis complete for treatment planning?' has a specific answer that depends on the material available.

Imaging records matter alongside pathology. Staging scans show where the disease was found at diagnosis. The specialist uses them to understand the extent described in your notes, not to re-diagnose from a single image. A scan report and the images themselves serve different purposes, and the treating team will say which they need.

  • Full pathology report, including addenda and molecular sections.
  • Stained slides or tissue block if the receiving centre requests material for re-reading.
  • Imaging reports and, where requested, the images themselves.
  • A short clinical summary: symptoms at diagnosis, dates, and treatments already given.

What remains uncertain when the review is remote

A records-based review cannot examine you. It cannot confirm how you are responding to any treatment already underway, and it cannot replace a physical assessment by the treating clinician. If you are currently receiving treatment, the review does not authorise stopping or changing it. Any decision about ongoing care belongs to the clinicians responsible for you now.

Remote review also cannot confirm hospital acceptance in advance. A specialist can give an opinion on the records, but admission, scheduling and final treatment decisions are made by the hospital after it assesses the case. The review tells you whether the diagnosis on file is clear enough to discuss treatment options; it does not reserve a bed or a place in a programme.

Some questions simply cannot be answered from documents: how a patient is tolerating treatment, what the physical examination shows, and what local imaging looks like today. Those belong to the treating team. A useful review states these limits plainly rather than filling the gaps with assumptions.

How to organise the gaps without ordering tests yourself

When records are incomplete, the practical step is to list what is missing and ask the receiving specialist which items actually matter for the decision. Not every absent document changes the plan. A missing scan from two years ago may be irrelevant; a missing marker from the diagnostic biopsy may be central. The specialist, not the patient, decides which gap is worth filling.

Do not arrange new tests, repeat biopsies or additional scans on your own before the review. Tests ordered without the treating team's context can add cost and confusion, and some may not be the right test for the question being asked. If the specialist needs something, they will specify it and explain why.

Keep the file organised by date and type. A clear index helps the reviewer move between the pathology report, the staging notes and the treatment history without guessing. It also makes it easier for you to see which questions have been answered and which are still open.

Questions that change the next step

The answers to a few questions determine whether a review can proceed, whether more records are needed, or whether the case is better handled closer to home. Ask them directly rather than assuming.

First: does the pathology report name a specific lymphoma subtype, and is the material available for re-reading if requested? Second: has the disease been staged, and are the staging records complete? Third: is treatment currently underway, and has the current treating team been informed that a review is being considered? Fourth: what does the specialist need that is not in the file?

If treatment is active, the review is a discussion alongside current care, not a replacement for it. If no treatment has started, the review can help clarify whether the diagnosis is complete before options are compared. The next step differs in each case, which is why the specialist's answer to these questions matters more than a general timeline.

Preparing the enquiry and what happens next

An initial enquiry is free and does not require buying a proxy consultation. Start with a short summary: the diagnosis as written, the date of the biopsy, whether treatment has begun, and your main question. Do not send passport numbers, payment details or a complete medical archive at first contact. The team will explain how to share records after the initial review.

The free initial case review checks the available diagnosis, records and your main question, identifies missing information and suggests the relevant next step. It is not a diagnosis and it cannot confirm acceptance. If a records-based specialist opinion is appropriate, that is a separate, optional step agreed in advance.

The hospital decides suitability. A pathology review clarifies the diagnosis; it does not establish treatment availability, trial enrolment or transplantation access. Keep the question narrow, keep the records accurate, and let the treating clinicians make the clinical decisions.

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. Related treatment reference
  2. NCI: Lymphoma Patient Version

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.